These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23401604)

  • 21. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
    Koch W; Radau PE; Hamann C; Tatsch K
    J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.
    Colloby SJ; O'Brien JT; Fenwick JD; Firbank MJ; Burn DJ; McKeith IG; Williams ED
    Neuroimage; 2004 Nov; 23(3):956-66. PubMed ID: 15528096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT.
    Soret M; Koulibaly PM; Darcourt J; Hapdey S; Buvat I
    J Nucl Med; 2003 Jul; 44(7):1184-93. PubMed ID: 12843235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
    J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
    Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A
    Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple algorithm for subregional striatal uptake analysis with partial volume correction in dopaminergic PET imaging.
    Lue KH; Lin HH; Kao CH; Hsieh HJ; Liu SH; Chuang KS
    Ann Nucl Med; 2014 Jan; 28(1):33-41. PubMed ID: 24135967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial intelligence in the diagnosis of Parkinson's disease from ioflupane-123 single-photon emission computed tomography dopamine transporter scans using transfer learning.
    Kim DH; Wit H; Thurston M
    Nucl Med Commun; 2018 Oct; 39(10):887-893. PubMed ID: 30080748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized image acquisition for dopamine transporter imaging with ultra-high resolution clinical pinhole SPECT.
    Chen Y; Vastenhouw B; Wu C; Goorden MC; Beekman FJ
    Phys Med Biol; 2018 Nov; 63(22):225002. PubMed ID: 30403197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
    Seibyl JP; Kupsch A; Booij J; Grosset DG; Costa DC; Hauser RA; Darcourt J; Bajaj N; Walker Z; Marek K; McKeith I; O'Brien JT; Tatsch K; Tolosa E; Dierckx RA; Grachev ID
    J Nucl Med; 2014 Aug; 55(8):1288-96. PubMed ID: 24925885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct spatiotemporal patterns for disease duration and stage in Parkinson's disease.
    Badoud S; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):509-16. PubMed ID: 26318603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism.
    Radau PE; Linke R; Slomka PJ; Tatsch K
    J Nucl Med; 2000 Feb; 41(2):220-7. PubMed ID: 10688103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency of
    Kotikova K; Zogala D; Ptacnik V; Trnka J; Kupka K; Vaneckova M; Seidl Z; Diblik P; Heissigerova J; Navratil T; Komarc M; Zak I; Polakova K; Brozova H; Zakharov S
    Clin Toxicol (Phila); 2021 Mar; 59(3):235-245. PubMed ID: 32762574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging.
    Rajeevan N; Zubal IG; Ramsby SQ; Zoghbi SS; Seibyl J; Innis RB
    J Nucl Med; 1998 Oct; 39(10):1719-26. PubMed ID: 9776276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification analysis of 123I-IPT single photon emission computed tomography uptake in the striatum of parkinsonism with the standard magnetic resonance template.
    Juh R; Pae CU; Lee CU; Kim J; Moon D; Suh T; Choe B
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):18-28. PubMed ID: 16472355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of
    Murakami H; Kimura A; Yasumoto T; Miki A; Yamamoto K; Ito N; Momma Y; Owan Y; Yano S; Ono K
    Front Aging Neurosci; 2018; 10():412. PubMed ID: 30618718
    [No Abstract]   [Full Text] [Related]  

  • 38. Parametrization of textural patterns in 123I-ioflupane imaging for the automatic detection of Parkinsonism.
    Martinez-Murcia FJ; Górriz JM; Ramírez J; Moreno-Caballero M; Gómez-Río M
    Med Phys; 2014 Jan; 41(1):012502. PubMed ID: 24387526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
    Booij J; Hemelaar TG; Speelman JD; de Bruin K; Janssen AG; van Royen EA
    J Nucl Med; 1999 May; 40(5):753-61. PubMed ID: 10319746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.